【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 16
1.2 List of Figures 21
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 24
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Etiology and Pathophysiology 25
3.1.1 Etiology 25
3.1.2 Pathophysiology 26
3.1.3 Prognosis and Quality of Life 28
3.2 Symptoms 29
3.2.1 Hemophilia A and B 29
3.2.2 Inhibitors 30
4 Epidemiology 31
4.1 Disease Background 31
4.2 Risk Factors and Comorbidities 32
4.3 Global Trends 33
4.4 Forecast Methodology 35
4.4.1 Sources Used 35
4.4.2 Sources Not Used 36
4.4.3 Forecast Assumptions and Methods 37
4.5 Epidemiological Forecast for Hemophilia A (2014-2024) 41
4.5.1 Diagnosed Prevalent Cases of Hemophilia A 41
4.5.2 Diagnosed Prevalent Cases of Hemophilia A by Age 42
4.5.3 Diagnosed Prevalent Cases of Hemophilia A by Sex 44
4.5.4 Age-Standardized Diagnosed Prevalence of Hemophilia A 46
4.6 Epidemiological Forecast for Hemophilia B (2014-2024) 47
4.6.1 Diagnosed Prevalent Cases of Hemophilia B 47
4.6.2 Diagnosed Prevalent Cases of Hemophilia B by Age 49
4.6.3 Diagnosed Prevalent Cases of Hemophilia B by Sex 51
4.6.4 Age-Standardized Diagnosed Prevalence of Hemophilia B 53
4.7 Epidemiological Forecast for Hemophilia A and Hemophilia B (2014-2024) 54
4.7.1 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B 54
4.7.2 Diagnosed Prevalent Cases of Hemophilia A and Hemophilia B by Sex 56
4.8 Discussion 58
4.8.1 Conclusions on Epidemiological Trends 58
4.8.2 Limitations of the Analysis 59
4.8.3 Strengths of the Analysis 60
5 Disease Management 61
5.1 Treatment Overview 61
5.1.1 Hemophilia A and B Diagnosis 61
5.1.2 Hemophilia A and B Treatment 62
5.1.3 Diagnosis of Inhibitors 64
5.1.4 Treatment of Inhibitors 65
5.2 US 67
5.2.1 Clinical Practice 67
5.3 France 69
5.3.1 Clinical Practice 69
5.4 Germany 71
5.4.1 Clinical Practice 71
5.5 Italy 73
5.5.1 Clinical Practice 73
5.6 Spain 75
5.6.1 Clinical Practice 75
5.7 UK 77
5.7.1 Clinical Practice 77
5.8 Japan 79
5.8.1 Clinical Practice 79
5.9 Argentina 81
5.9.1 Clinical Practice 81
6 Competitive Assessment 83
6.1 Overview 83
6.2 Strategic Competitive Assessment 83
6.3 Product Profiles – Hemophilia A 86
6.3.1 Advate (Octocog Alfa) 86
6.3.2 Kogenate FS/Helixate FS (Octocog Alfa) 92
6.3.3 Xyntha/ReFacto AF (Moroctocog Alfa) 99
6.3.4 Recombinate (Octocog Alfa) 103
6.3.5 Eloctate (Efmoroctocog Alfa) 107
6.3.6 NovoEight (Turoctocog Alfa) 113
6.3.7 Nuwiq (Simoctocog Alfa) 118
6.4 Product Profiles – Hemophilia B 123
6.4.1 BeneFIX (Nonacog Alfa) 123
6.4.2 Alprolix (Eftrenonacog Alfa) 128
6.4.3 Rixubis (Nonacog Gamma) 134
6.4.4 IXinity (Trenonacog Alfa) 138
6.5 Product Profiles – Hemophilia A and B with Inhibitors 143
6.5.1 NovoSeven RT (Eptacog Alfa) 143
7 Opportunity and Unmet Need 149
7.1 Overview 149
7.2 Opportunity Analysis 150
7.2.1 Longer-Lasting Recombinant Factors 150
7.2.2 Lower-Cost Recombinant Replacement Therapies 151
7.2.3 Lower Risk of Inhibitor Formation in Previously Untreated Patients 153
7.2.4 More Convenient Drug Administration 154
7.3 Unmet Needs Gap Analysis 154
7.3.1 Long-Acting FVIII Replacement Therapies 154
7.3.2 Gene Therapy Treatments for Hemophilia A and B 155
8 Pipeline Assessment 157
8.1 Overview 157
8.2 Late-Stage Development Candidates – Hemophilia A 158
8.2.1 Kovaltry (Octocog Alfa; BAY 81-8973) 159
8.2.2 Adynovate (BAX-855) 164
8.2.3 BAY 94-9027 (Damoctocog Alfa Pegol) 169
8.2.4 N8-GP (Turoctocog Alfa Pegol) 175
8.2.5 CSL-627 (rFVIII-SC) 181
8.2.6 GreenGene F (Beroctocog Alfa; GC1101C) 186
8.3 Late-Stage Development Candidates – Hemophilia B 192
8.3.1 CSL-654 (rIX-FP; Albutrepenonacog Alfa) 193
8.3.2 N9-GP (NN-7999; Nonacog Beta Pegol) 197
8.4 Late-Stage Development Candidates – Hemophilia A and B Bypassing Agents (Patients with Inhibitors) 203
8.4.1 BAX-817 (rFVIIa BI) 204
8.4.2 LR-769 (rhFVIIa) 209
8.4.3 CSL-689 (rVIIa-FP) 215
8.5 Promising Drugs in Early-Stage Development 220
8.5.1 Alternative Coagulation Promoters 220
8.5.2 Gene Therapies 223
9 Current and Future Players 227
9.1 Overview 227
9.2 Trends in Corporate Strategy 229
9.3 Company Profiles 229
9.3.1 Baxalta 229
9.3.2 Bayer 233
9.3.3 Biogen 235
9.3.4 CSL Behring 237
9.3.5 Novo Nordisk 239
9.3.6 Pfizer 242
10 Market Outlook 244
10.1 Global Markets 244
10.1.1 Forecast 244
10.1.2 Drivers and Barriers – Global Market 247
10.2 US 250
10.2.1 Forecast 250
10.2.2 Key Events 254
10.2.3 Drivers and Barriers 254
10.3 5EU 255
10.3.1 Forecast 255
10.3.2 Key Events 259
10.3.3 Drivers and Barriers – France 260
10.3.4 Drivers and Barriers – Germany 262
10.3.5 Drivers and Barriers – Italy 263
10.3.6 Drivers and Barriers – Spain 264
10.3.7 Drivers and Barriers – UK 265
10.4 Japan 266
10.4.1 Forecast 266
10.4.2 Key Events 270
10.4.3 Drivers and Barriers 270
10.5 Argentina 272
10.5.1 Forecast 272
10.5.2 Key Events 277
10.5.3 Drivers and Barriers 277
11 Appendix 279
11.1 Bibliography 279
11.2 Abbreviations 306
11.3 Methodology 309
11.4 Forecasting Methodology 309
11.4.1 Diagnosed Hemophilia Patients 309
11.4.2 Percent Drug-Treated Patients 310
11.4.3 Drugs Included in Each Therapeutic Class 310
11.4.4 Launch Dates 311
11.4.5 General Pricing Assumptions 312
11.4.6 Individual Drug Assumptions 313
11.4.7 Pricing of Pipeline Agents 322
11.5 Primary Research – KOLs Interviewed for this Report 323
11.6 Primary Research – Prescriber Survey 327
11.7 Real-World Data 327
11.8 About the Authors 329
11.8.1 Analyst 329
11.8.2 Therapy Area Director 329
11.8.3 Epidemiologists 329
11.8.4 Global Head of Healthcare 331
11.9 About GlobalData 332
11.10 Disclaimer 332
【レポート販売概要】
■ タイトル:血友病A・血友病Bの組換え因子補充療法:世界の薬剤市場予測・分析■ 英文:PharmaPoint: Hemophilia A and B Recombinant Factor Replacement Therapy - Global Drug Forecast and Market Analysis to 2024
■ 発行日:2015年12月
■ 調査会社:GlobalData
■ 商品コード:GDHC116PIDR
■ 調査対象地域:グローバル
- 小動物向け画像診断機器(イン・ビトロ)の世界市場予測(~2021年):光学イメージング、PET、SPECT、CT、MRI、超音波、光音響画像化装置、磁気粒子画像装置The global small animal imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researche …
- メチルエチルケトン(MEK/ブタノン)の世界市場2015-2019About MEK MEK also known as butanone is a colorless organic solvent with a pleasant pungent odor. It is used as a solvent for multiple applications due to its outstanding chemical properties such as high viscosity, high evaporation rate, low boiling point, and high solvency. MEK is used in paints and coatings, adhesives and thinners, printing inks, pharmaceutical products, and others. Technavio's …
- 世界のマネージド・サービス市場(2014-2018)About Managed Services With the increase in globalization and complexity of the global business landscape, companies are turning toward smarter and easily achievable solutions to address their business needs. From cost-cutting to focusing on core competencies, all of these objectives can be achieved through the adoption of managed services. The increase in the complexity of the issues related to d …
- ミネラル化粧品の世界市場:製品種類別(フェイス化粧品、リップ化粧品、アイ化粧品)、流通チャンネル別(小売流通、Eコマース、ビューティーセンター&スパ)The global cosmetics mineral market size was valued at $2,105.5 million in 2019 and is expected to grow at a CAGR of 4.7% to reach $2,916.4 million by 2026. Mineral cosmetic is a type of makeup made of natural minerals such as iron oxides, zinc oxide, titanium dioxide, mica powder, and organic oils. Mineral cosmetic is not derived from plant sources and does not comprise any oil or wax additives. …
- 世界の掘削機市場(2014-2018)About Excavator Market The The Global Construction Equipment market has experienced several pitfalls in the past decade due to the global economic recession. Excavators form an integral part of the Global Construction Equipment market; therefore, they experienced a decrease in their demand during the recession. There are two types of excavators: mini/midi excavators and crawler/wheeled excavators. …
- グリーン及びバイオ溶剤の世界市場:バイオアルコール、バイオグリコール、バイオジオール、乳酸エステル、D-リモネン、メチルソイアートThe green & bio-solvents market size, in terms of value, is estimated to reach USD 8.17 Billion by 2020, signifying a firm CAGR of over 7.94% between 2015 and 2020. The drivers identified for the green & bio-solvents market are environmental & regulatory pressure designed to reduce the emissions of ODS, VOCs, and HAPs; reduced dependency on petrochemical solvents and the exporting countries; impro …
- エンタープライズメディアゲートウェイの世界市場2016-2020About Enterprise Media Gateway Enterprise media gateway is a device that converts voice communication into digital signals and carries signals over the internet protocol (IP) network. IP-based communications such as unified communication and voice over internet protocol (VoIP) are cost-effective solutions and offer quality communication service to end-users. Also, these devices require initial inv …
- 構造健全性監視の世界市場予測(~2022):ソリューション別(ハードウェア:センサー、データ収集システム;ソフトウェア&サービス)、技術別、需要先別、地域別According to the MarketsandMarkets forecast, the structural health monitoring market is expected to grow from USD 701.4 Million in 2015 to USD 3407.7 Million by 2022, at a CAGR of 24.99% between 2016 and 2022. Structural health monitoring solutions are used across various sectors such as civil infrastructure, aerospace, energy, mining, and others. The increasing initiatives of governments worldwid …
- 自動車用ダイナミックステアリング装置の世界市場2017-2021About Automotive Dynamic Steering System An automotive dynamic steering system is an advanced system that alters or modifies the characteristics of steering system to adapt to the present vehicle speed and on-road conditions. The advanced steering response or control system aids in better handling by providing adequate feedback of the road and adjusting itself as per the road conditions. The syste …
- インシデントレスポンスシステムの世界市場:地理空間技術、バックアップ・ディザスタリカバリ、脅威管理、監視システムAbout Incident Response Incident response is a synchronized effort to address and manage an attack or a security breach after detection. It helps restrict the damage and cut recovery costs and time. An incident response system comprises a response plan that should be followed by the occurrence of an incident. Organization members from departments such as IT staff, security, public relation, and hu …
- メタリック顔料の世界市場2017-2021:アルミニウム顔料、銅顔料、亜鉛顔料、ステンレス鋼顔料About Metallic Pigments Metallic pigments are inorganic pigments with metallic characteristics. These pigments are flake-shaped metallic particles that are available as pastes, powders, pellets, suspensions, or color concentrates. Metallic pigments usually consist of aluminum, gold, zinc, bronze, stainless steel, and nickel. These pigments are used in anticorrosion, heat resistant, reflective, and …
- デジタルメディア支出の世界市場:サーチ広告、ディスプレイ広告、ソーシャルメディア、EメールマーケティングAbout Digital Marketing Digital marketing is the most active and the fastest growing marketing technique. The growth can be attributed to global digitalization trend. Every minute, an estimated 650,000 search queries are raised on Google, more than 700 videos are hosted on YouTube, over 700,000 status updates and 500,000 comments are posted on Facebook, over 65,000 tweets are made worldwide, and a …
- 風力タービン(風力原動機)の世界市場:市場規模、価格、市場シェア、主要国分析Wind Turbine Market, Update 2015 - Market Size, Average Price, Market Share and Key Country Analysis to 2020 Summary "Wind Turbine Market, Update 2015 - Market Size, Average Price, Market Share and Key Country Analysis to 2020" is the latest market analysis report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the power industry. The re …
- 自動車触媒コンバーターの世界市場:三元触媒、リーンNOx触媒、リーンNOxトラップ触媒、選択触媒還元、ディーゼル酸化触媒About Automotive Catalytic Converter A catalytic converter is a device used to convert exhaust emissions such as CO, HC, and NOx into less harmful emissions such as CO2, water, and N2. Precious metals such as platinum, palladium, rhodium, and vanadium are used as a catalyst coat on the ceramic beads in the catalytic converter for the conversion. The automotive catalytic converters are highly price …
- プレイアウト自動化の世界市場2016-2020About Playout Automation Playout automation is a technology that integrates all the devices involved in a playout chain (such as video routers, switchers, audio servers, channel branding processors, and graphic inserts) in a single device. Playout automation takes control of multiple devices involved in a playout chain, whereas integrated playout automation uses a single device to perform the func …